<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Incyte - Wikipedia</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"XpoLogpAMNMAAe2BKvUAAAEC","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Incyte","wgTitle":"Incyte","wgCurRevisionId":928014151,"wgRevisionId":928014151,"wgArticleId":35741235,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Incyte","wgRelevantArticleId":35741235,"wgIsProbablyEditable":!0,"wgRelevantPageIsProbablyEditable":!0,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":!0,"wgMediaViewerEnabledByDefault":!0,"wgPopupsReferencePreviews":!1,
"wgPopupsConflictsWithNavPopupGadget":!1,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFMode":"stable","wgMFAmc":!1,"wgMFAmcOutreachActive":!1,"wgMFAmcOutreachUserEligible":!1,"wgMFLazyLoadImages":!0,"wgMFDisplayWikibaseDescriptions":{"search":!0,"nearby":!0,"watchlist":!0,"tagline":!1},"wgMFIsPageContentModelEditable":!0,"wgWMESchemaEditAttemptStepOversample":!1,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q6015591","wgCentralAuthMobileDomain":!0,"wgEditSubmitButtonLabelPublish":!0,"wgMinervaPermissions":{"watch":!0,"talk":!1},"wgMinervaFeatures":{"beta":!1,"mobileOptionsLink":!0,"categories":!1,"pageIssues":!0,"talkAtTop":!1,"historyInPageActions":!1,"overflowSubmenu":!1,"tabsOnSpecials":!1,"personalMenu":!1,"mainMenuExpanded":!1,"simplifiedTalk":!0},"wgMinervaDownloadNamespaces":[0]};RLSTATE={"site.styles":"ready","noscript":
"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.minerva.base.styles":"ready","skins.minerva.content.styles":"ready","skins.minerva.content.styles.images":"ready","mediawiki.hlist":"ready","mediawiki.ui.icon":"ready","mediawiki.ui.button":"ready","skins.minerva.icons.wikimedia":"ready","skins.minerva.mainMenu.icons":"ready","skins.minerva.mainMenu.styles":"ready","mobile.init.styles":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["site","mediawiki.page.startup","skins.minerva.options","skins.minerva.scripts","ext.gadget.switcher","ext.centralauth.centralautologin","ext.popups","mobile.init","ext.relatedArticles.readMore.bootstrap","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","mw.externalguidance.init","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.wikimediaBadges%7Cmediawiki.hlist%7Cmediawiki.ui.button%2Cicon%7Cmobile.init.styles%7Cskins.minerva.base.styles%7Cskins.minerva.content.styles%7Cskins.minerva.content.styles.images%7Cskins.minerva.icons.wikimedia%7Cskins.minerva.mainMenu.icons%2Cstyles&amp;only=styles&amp;skin=minerva"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=minerva&amp;target=mobile"></script>
<meta name="generator" content="MediaWiki 1.35.0-wmf.28"/>
<meta name="referrer" content="origin"/>
<meta name="referrer" content="origin-when-crossorigin"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<meta name="theme-color" content="#eaecf0"/>
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/en/thumb/5/5a/Incyte_logo.svg/1200px-Incyte_logo.svg.png"/>
<meta name="viewport" content="initial-scale=1.0, user-scalable=yes, minimum-scale=0.25, maximum-scale=5.0, width=device-width"/>
<link rel="manifest" href="/w/api.php?action=webapp-manifest"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Incyte&amp;action=edit"/>
<link rel="edit" title="Edit this page" href="/w/index.php?title=Incyte&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="license" href="//creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Incyte"/>
<link rel="dns-prefetch" href="//login.wikimedia.org"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Incyte rootpage-Incyte stable issues-group-B skin-minerva action-view">
<div id="mw-mf-viewport">
	<div id="mw-mf-page-center">
		<a class="mw-mf-page-center__mask" href="#"></a>
		<header class="header-container header-chrome">
			<form class="header" action="/w/index.php" method="get">
				<nav class="navigation-drawer toggle-list view-border-box">
					<input type="checkbox" id="main-menu-input" class="toggle-list__checkbox" role="button" aria-labelledby="mw-mf-main-menu-button">
					<label for="main-menu-input" id="mw-mf-main-menu-button"
						class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-menu-base20 mw-ui-icon-flush-left toggle-list__toggle"
						title="Open main menu" data-event-name="ui.mainmenu">Open main menu</label>
					<div id="mw-mf-page-left" class="menu toggle-list__list view-border-box">
	<ul id="p-navigation">
			<li class="">
			    <a href="/wiki/Main_Page" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-home" data-event-name="menu.home"><span>Home</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Special:Random#/random" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-die " data-event-name="menu.random"><span>Random</span></a>
			</li>
			<li class="jsonly">
			    <a href="/wiki/Special:Nearby" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-mapPin nearby" data-event-name="menu.nearby"><span>Nearby</span></a>
			</li>
	</ul>
	<ul id="p-personal">
			<li class="">
			    <a href="/w/index.php?title=Special:UserLogin&amp;returnto=Incyte" class="menu__item--login mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-logIn " data-event-name="menu.login"><span>Log in</span></a>
			</li>
	</ul>
	<ul id="pt-preferences">
			<li class="jsonly">
			    <a href="/w/index.php?title=Special:MobileOptions&amp;returnto=Incyte" class="menu__item--settings mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-settings " data-event-name="menu.settings"><span>Settings</span></a>
			</li>
	</ul>
	<ul class="hlist">
			<li class="">
			    <a href="/wiki/Wikipedia:About" class="" data-event-name=""><span>About Wikipedia</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Wikipedia:General_disclaimer" class="" data-event-name=""><span>Disclaimers</span></a>
			</li>
	</ul>
</div>

					<label class="main-menu-mask" for="main-menu-input"></label>
				</nav>
				<div class="branding-box">
					<a href="/wiki/Main_Page">
						<span><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></span>
						
					</a>
				</div>
				<div class="search-box">
					<input class="search mw-ui-background-icon-search skin-minerva-search-trigger" type="search" name="search" id="searchInput"
						autocomplete="off" placeholder="Search Wikipedia" aria-label="Search Wikipedia"
						value="">
				</div>
				<nav class="minerva-user-navigation" aria-label="User navigation">
					<div><button id="searchIcon" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-search-base20 skin-minerva-search-trigger" type="submit">Search</button></div>
					
				</nav>
			</form>
		</header>
		<main id="content" class="mw-body">
			<div class="banner-container">
			<div id="siteNotice"></div>
			</div>
			
			<div class="pre-content heading-holder">
				<div class="page-heading">
					<h1 id="section_0">Incyte</h1>
					<div class="tagline"></div>
				</div>
				<nav class="page-actions-menu">
	<ul id="page-actions" class="page-actions-menu__list">
		<li id="language-selector" class="page-actions-menu__list-item">
				<a id="" href="/wiki/Special:MobileLanguages/Incyte" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-language-base20 mw-ui-icon-with-label-desktop language-selector"
					data-mw="interface"
					data-event-name="menu.languages" role="button" title="Language">Language</a>
		</li>
		<li id="page-actions-watch" class="page-actions-menu__list-item">
				<a id="ca-watch" href="/w/index.php?title=Special:UserLogin&amp;returnto=Incyte" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-star-base20 mw-ui-icon-with-label-desktop watch-this-article mw-watchlink menu__item--page-actions-watch"
					data-mw="interface"
					data-event-name="menu.watch" role="button" title="Watch">Watch</a>
		</li>
		<li id="page-actions-edit" class="page-actions-menu__list-item">
				<a id="ca-edit" href="/w/index.php?title=Incyte&amp;action=edit&amp;section=0" class="edit-page menu__item--page-actions-edit mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 mw-ui-icon-with-label-desktop"
					data-mw="interface"
					data-event-name="menu.edit" role="button" title="Edit the lead section of this page">Edit</a>
		</li>
	</ul>
</nav>
<!-- version 1.0.2 (change every time you update a partial) -->

				
				
				<div class="minerva__subtitle"></div>
			</div>
			
			<div id="bodyContent" class="content"><div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><script>function mfTempOpenSection(id){var block=document.getElementById("mf-section-"+id);block.className+=" open-block";block.previousSibling.className+=" open-block";}</script><div class="mw-parser-output"><section class="mf-section-0" id="mf-section-0"><p><b>Incyte Corp</b> is an American <a href="/wiki/Pharmaceutical_company" class="mw-redirect" title="Pharmaceutical company">pharmaceutical company</a> based in <a href="/wiki/Alapocas,_Delaware" title="Alapocas, Delaware">Alapocas, Delaware</a>.<sup id="cite_ref-natoli2012_3-0" class="reference"><a href="#cite_note-natoli2012-3">[3]</a></sup>  The company was founded in Palo Alto, California in 1991 and went public in 1993.<sup id="cite_ref-top_1-1" class="reference"><a href="#cite_note-top-1">[1]</a></sup></p><table class="infobox vcard" style="width:22em"><caption class="fn org">Incyte Corporation</caption><tbody><tr><td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:Incyte_logo.svg" class="image"><img alt="Incyte logo.svg" src="//upload.wikimedia.org/wikipedia/en/thumb/5/5a/Incyte_logo.svg/200px-Incyte_logo.svg.png" decoding="async" width="200" height="134" srcset="//upload.wikimedia.org/wikipedia/en/thumb/5/5a/Incyte_logo.svg/300px-Incyte_logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/5/5a/Incyte_logo.svg/400px-Incyte_logo.svg.png 2x" data-file-width="61" data-file-height="41"></a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/List_of_legal_entity_types_by_country" title="List of legal entity types by country">Type</a></div></th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Public_company" title="Public company">Public</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/Ticker_symbol" title="Ticker symbol">Traded as</a></th><td style="line-height: 1.35em;"><a href="/wiki/NASDAQ" class="mw-redirect" title="NASDAQ">NASDAQ</a>: <a rel="nofollow" class="external text" href="https://www.nasdaq.com/symbol/incy">INCY</a><br><a href="/wiki/NASDAQ-100" title="NASDAQ-100">NASDAQ-100 Component</a><br><a href="/wiki/S%26P_500" class="mw-redirect" title="S&amp;P 500">S&amp;P 500 Component</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/International_Securities_Identification_Number" title="International Securities Identification Number">ISIN</a></th><td style="line-height: 1.35em;"><span class="plainlinks nourlexpansion"><a class="external text" href="https://tools.wmflabs.org/isin/?language=en&amp;isin=US45337C1027">US45337C1027 </a><a href="https://www.wikidata.org/wiki/Q6015591?uselang=en#P946" title="Edit this on Wikidata"><img alt="Edit this on Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20"></a></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Industry</th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Pharmaceutical_company" class="mw-redirect" title="Pharmaceutical company">pharmaceutical company</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founded</th><td style="line-height: 1.35em;">1991<span style="display:none"> (<span class="bday dtstart published updated">1991</span>)</span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Headquarters</th><td class="adr" style="line-height: 1.35em;"><div style="display: inline;" class="locality"><a href="/wiki/Wilmington,_Delaware" title="Wilmington, Delaware">Wilmington, Delaware</a></div>, <div style="display: inline;" class="country-name">United States</div></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Key people</div></th><td class="agent" style="line-height: 1.35em;">Hervé Hoppenot (President and CEO, 2014)</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Revenue</th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <a href="/wiki/%24US" class="mw-redirect" title="$US">$US</a> 1.5 billion (2017)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Net_income" title="Net income">Net income</a></div></th><td style="line-height: 1.35em;"><img alt="Decrease" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png" decoding="async" title="Decrease" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x" data-file-width="300" data-file-height="300"> <a href="/wiki/%24US" class="mw-redirect" title="$US">$US</a> (313) million (2017)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Asset" title="Asset">Total assets</a></span></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <a href="/wiki/%24US" class="mw-redirect" title="$US">$US</a> 1.504 billion (2017)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Equity_(finance)" title="Equity (finance)">Total equity</a></span></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <a href="/wiki/%24US" class="mw-redirect" title="$US">$US</a> 1.632 billion (2017)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Number of employees</div></th><td style="line-height: 1.35em;">~700<sup id="cite_ref-top_1-0" class="reference"><a href="#cite_note-top-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Website</th><td style="line-height: 1.35em;"><span class="url"><a rel="nofollow" class="external text" href="http://www.incyte.com">www.incyte.com</a></span></td></tr><tr><td colspan="2" style="text-align:center;line-height: 1.35em;"><b>Footnotes / references</b><br><sup id="cite_ref-2011_10K_2-0" class="reference"><a href="#cite_note-2011_10K-2">[2]</a></sup></td></tr></tbody></table><p>Incyte has one drug, <a href="/wiki/Jakafi" class="mw-redirect" title="Jakafi">Jakafi</a>, which has been approved by the U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) and has been prescribed to patients in the United States.<sup id="cite_ref-natoli2012_3-1" class="reference"><a href="#cite_note-natoli2012-3">[3]</a></sup></p><p>As of 2014, the company was developing <a href="/wiki/Baricitinib" title="Baricitinib">baricitinib</a>, an oral <a href="/wiki/JAK_inhibitor" class="mw-redirect" title="JAK inhibitor">JAK1 and JAK2 inhibitor</a> drug for <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a> in partnership with <a href="/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company">Eli Lilly</a>.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4">[4]</a></sup><sup id="cite_ref-urlwww.ama-assn.org_5-0" class="reference"><a href="#cite_note-urlwww.ama-assn.org-5">[5]</a></sup> It gained EU approval in February 2017.<sup id="cite_ref-EMA-authorisation_6-0" class="reference"><a href="#cite_note-EMA-authorisation-6">[6]</a></sup> In April 2017, the <a href="/wiki/US_FDA" class="mw-redirect" title="US FDA">US FDA</a> issued a rejection, citing concerns about dosing and safety.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7">[7]</a></sup><sup id="cite_ref-8" class="reference"><a href="#cite_note-8">[8]</a></sup></p><p>As of 2016 <a href="/wiki/Epacadostat" title="Epacadostat">epacadostat</a>, an <a href="/wiki/Indoleamine_2,3-dioxygenase" title="Indoleamine 2,3-dioxygenase">indoleamine 2,3-dioxygenase</a> (IDO1) inhibitor, was in development for various cancers and was in combination trials with Merck's <a href="/wiki/Pembrolizumab" title="Pembrolizumab">pembrolizumab</a> (Keytruda) and Bristol Myers Squibb's <a href="/wiki/Nivolumab" title="Nivolumab">nivolumab</a> (Opdivo).<sup id="cite_ref-9" class="reference"><a href="#cite_note-9">[9]</a></sup><sup id="cite_ref-10" class="reference"><a href="#cite_note-10">[10]</a></sup></p><p>Novartis acquired Incyte's <a href="/wiki/C-Met_inhibitor" title="C-Met inhibitor">c-Met inhibitor</a> <b>capmatinib</b> (INC280,  INCB028060), which is in Phase II clinical trial as monotherapy in patients with advanced <a href="/wiki/Hepatocellular_carcinoma" title="Hepatocellular carcinoma">hepatocellular carcinoma</a>.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11">[11]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(1)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="History">History</span><span class="mw-editsection"><a href="/w/index.php?title=Incyte&amp;action=edit&amp;section=1" title="Edit section: History" data-section="1" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-1 collapsible-block" id="mf-section-1">
<p>In 2014, Incyte named Hervé Hoppenot president and CEO.<sup id="cite_ref-geneng20140215_12-0" class="reference"><a href="#cite_note-geneng20140215-12">[12]</a></sup>  Hoppenot had previously served as the president of <a href="/wiki/Novartis" title="Novartis">Novartis</a> Oncology; he had been with Novartis since 2003.<sup id="cite_ref-geneng20140215_12-1" class="reference"><a href="#cite_note-geneng20140215-12">[12]</a></sup></p><p>In September 2015, the company announced it had gained exclusive development and commercial right pertaining to Jiangsu Hengrui Medicine Co., Ltd's <a href="/wiki/Anti-PD-1" class="mw-redirect" title="Anti-PD-1">anti-PD-1</a> <a href="/wiki/Monoclonal_antibody" title="Monoclonal antibody">monoclonal antibody</a>, <a href="/w/index.php?title=SHR-1210&amp;action=edit&amp;redlink=1" class="new" title="SHR-1210 (page does not exist)">SHR-1210</a>, in a deal worth $795+ million.<sup id="cite_ref-url_GEN_News_Highlights_13-0" class="reference"><a href="#cite_note-url_GEN_News_Highlights-13">[13]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(2)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="References">References</span><span class="mw-editsection"><a href="/w/index.php?title=Incyte&amp;action=edit&amp;section=2" title="Edit section: References" data-section="2" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-2 collapsible-block" id="mf-section-2">
<div class="reflist" style="list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="references"><li id="cite_note-top-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-top_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-top_1-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Scott Goss (2 Mar 2015). <a rel="nofollow" class="external text" href="http://www.delawareonline.com/story/money/business/2015/03/02/incyte-wins-delaware-bio-company-year-honor/24282977/">"Incyte is Delaware Bio Company of the Year, again"</a>. <i>delawareonline.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2 Mar</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=delawareonline.com&amp;rft.atitle=Incyte+is+Delaware+Bio+Company+of+the+Year%2C+again&amp;rft.date=2015-03-02&amp;rft.au=Scott+Goss&amp;rft_id=http%3A%2F%2Fwww.delawareonline.com%2Fstory%2Fmoney%2Fbusiness%2F2015%2F03%2F02%2Fincyte-wins-delaware-bio-company-year-honor%2F24282977%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncyte" class="Z3988"></span><style data-mw-deduplicate="TemplateStyles:r935243608">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}</style></span>
</li>
<li id="cite_note-2011_10K-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2011_10K_2-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFIncyte_Corporation2012" class="citation">Incyte Corporation (2012), <a rel="nofollow" class="external text" href="https://archive.today/20130126183519/http://investor.incyte.com/phoenix.zhtml?c=69764&amp;p=IROL-secToc&amp;TOC=aHR0cDovL2lyLmludC53ZXN0bGF3YnVzaW5lc3MuY29tL2RvY3VtZW50L3YxLzAwMDEwNDc0NjktMTItMDAxMjk1L3RvYy9wYWdl&amp;ListAll=1&amp;sXBRL=1"><i>Form 10-K</i></a> (<a href="/wiki/SEC_filing" title="SEC filing">SEC filing</a>), Incyte Corporation (published February 22, 2012), Commission File Number: 0-27488, archived from <a rel="nofollow" class="external text" href="http://investor.incyte.com/phoenix.zhtml?c=69764&amp;p=IROL-secToc&amp;TOC=aHR0cDovL2lyLmludC53ZXN0bGF3YnVzaW5lc3MuY29tL2RvY3VtZW50L3YxLzAwMDEwNDc0NjktMTItMDAxMjk1L3RvYy9wYWdl&amp;ListAll=1&amp;sXBRL=1">the original</a> on January 26, 2013<span class="reference-accessdate">, retrieved <span class="nowrap">May 6,</span> 2012</span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Form+10-K&amp;rft.pub=Incyte+Corporation&amp;rft.date=2012&amp;rft.au=Incyte+Corporation&amp;rft_id=http%3A%2F%2Finvestor.incyte.com%2Fphoenix.zhtml%3Fc%3D69764%26p%3DIROL-secToc%26TOC%3DaHR0cDovL2lyLmludC53ZXN0bGF3YnVzaW5lc3MuY29tL2RvY3VtZW50L3YxLzAwMDEwNDc0NjktMTItMDAxMjk1L3RvYy9wYWdl%26ListAll%3D1%26sXBRL%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncyte" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-natoli2012-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-natoli2012_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-natoli2012_3-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFNatoli2012" class="citation">Natoli, Cori Anne (May 5, 2012), <a rel="nofollow" class="external text" href="http://www.delawareonline.com/article/20120506/BUSINESS/205060304/Incyte-looks-to-ride-on-drug-s-success">"Incyte looks to ride on drug's success"</a>, <i><a href="/wiki/The_News_Journal" title="The News Journal">The News Journal</a></i><span class="reference-accessdate">, retrieved <span class="nowrap">May 6,</span> 2012</span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+News+Journal&amp;rft.atitle=Incyte+looks+to+ride+on+drug%27s+success&amp;rft.date=2012-05-05&amp;rft.aulast=Natoli&amp;rft.aufirst=Cori+Anne&amp;rft_id=http%3A%2F%2Fwww.delawareonline.com%2Farticle%2F20120506%2FBUSINESS%2F205060304%2FIncyte-looks-to-ride-on-drug-s-success&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncyte" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://archive.today/20150308124051/https://www.insideindianabusiness.com/newsitem.asp?ID=68416">"Lilly, Incyte Treatment Shows Positive Results"</a>. <i>www.insideindianabusiness.com</i>. 9 Dec 2014. Archived from <a rel="nofollow" class="external text" href="https://www.insideindianabusiness.com/newsitem.asp?ID=68416">the original</a> on 8 March 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">2 Mar</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.insideindianabusiness.com&amp;rft.atitle=Lilly%2C+Incyte+Treatment+Shows+Positive+Results&amp;rft.date=2014-12-09&amp;rft_id=https%3A%2F%2Fwww.insideindianabusiness.com%2Fnewsitem.asp%3FID%3D68416&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncyte" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-urlwww.ama-assn.org-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlwww.ama-assn.org_5-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.ama-assn.org/resources/doc/usan/baricitinib.pdf">"Baricitinib"</a> <span class="cs1-format">(pdf)</span>. <i>Statement on a nonproprietary name adopted by the USAN council</i>. American Medical Association.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Statement+on+a+nonproprietary+name+adopted+by+the+USAN+council&amp;rft.atitle=Baricitinib&amp;rft_id=http%3A%2F%2Fwww.ama-assn.org%2Fresources%2Fdoc%2Fusan%2Fbaricitinib.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncyte" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-EMA-authorisation-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-EMA-authorisation_6-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004085/human_med_002074.jsp&amp;mid=WC0b01ac058001d124">"Olumiant: Authorisation details"</a>. <a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a>. 16 March 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Olumiant%3A+Authorisation+details&amp;rft.pub=European+Medicines+Agency&amp;rft.date=2017-03-16&amp;rft_id=http%3A%2F%2Fwww.ema.europa.eu%2Fema%2Findex.jsp%3Fcurl%3Dpages%2Fmedicines%2Fhuman%2Fmedicines%2F004085%2Fhuman_med_002074.jsp%26mid%3DWC0b01ac058001d124&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncyte" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><cite class="citation news">Ramsey, L (17 April 2017). <a rel="nofollow" class="external text" href="http://www.businessinsider.com/fda-rejects-lilly-and-incytes-baricitinib-2017-4">"The FDA shot down a new rheumatoid arthritis drug — and the companies that make the drug are tumbling"</a>. Business Insider.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+FDA+shot+down+a+new+rheumatoid+arthritis+drug+%E2%80%94+and+the+companies+that+make+the+drug+are+tumbling&amp;rft.date=2017-04-17&amp;rft.au=Ramsey%2C+L&amp;rft_id=http%3A%2F%2Fwww.businessinsider.com%2Ffda-rejects-lilly-and-incytes-baricitinib-2017-4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncyte" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><cite class="citation news">Grant, Ch (14 April 2017). <a rel="nofollow" class="external text" href="https://www.wsj.com/articles/surprise-fda-rejection-will-sting-this-biotech-1492185721">"Surprise FDA Rejection Will Sting This Biotech"</a>. The Wall Street Journal.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Surprise+FDA+Rejection+Will+Sting+This+Biotech&amp;rft.date=2017-04-14&amp;rft.au=Grant%2C+Ch&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fsurprise-fda-rejection-will-sting-this-biotech-1492185721&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncyte" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><cite class="citation journal">Brochez, L; Chevolet, I; Kruse, V (May 2017). "The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy". <i>European journal of cancer (Oxford, England : 1990)</i>. <b>76</b>: 167–182. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ejca.2017.01.011">10.1016/j.ejca.2017.01.011</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28324751">28324751</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+journal+of+cancer+%28Oxford%2C+England+%3A+1990%29&amp;rft.atitle=The+rationale+of+indoleamine+2%2C3-dioxygenase+inhibition+for+cancer+therapy.&amp;rft.volume=76&amp;rft.pages=167-182&amp;rft.date=2017-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ejca.2017.01.011&amp;rft_id=info%3Apmid%2F28324751&amp;rft.aulast=Brochez&amp;rft.aufirst=L&amp;rft.au=Chevolet%2C+I&amp;rft.au=Kruse%2C+V&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncyte" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><cite class="citation news">Tracy Staton (Apr 3, 2017). <a rel="nofollow" class="external text" href="http://www.fiercepharma.com/marketing/racing-lung-cancer-again-or-still-merck-and-bms-expand-incyte-combo-trials">"Racing in lung cancer again (or still), Merck and BMS expand Incyte combo trials"</a>. FiercePharma.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Racing+in+lung+cancer+again+%28or+still%29%2C+Merck+and+BMS+expand+Incyte+combo+trials&amp;rft.date=2017-04-03&amp;rft.au=Tracy+Staton&amp;rft_id=http%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fracing-lung-cancer-again-or-still-merck-and-bms-expand-incyte-combo-trials&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncyte" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.businesswire.com/news/home/20130429005612/en/Incyte-Achieves-25-Million-Milestone-c-MET-Inhibitor">"Incyte Achieves $25 Million Milestone as c-MET Inhibitor INC280 Advances Into Phase II Development | Business Wire"</a>. <i>www.businesswire.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2015-12-29</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.businesswire.com&amp;rft.atitle=Incyte+Achieves+%2425+Million+Milestone+as+c-MET+Inhibitor+INC280+Advances+Into+Phase+II+Development+%7C+Business+Wire&amp;rft_id=http%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20130429005612%2Fen%2FIncyte-Achieves-25-Million-Milestone-c-MET-Inhibitor&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncyte" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-geneng20140215-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-geneng20140215_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-geneng20140215_12-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">"People". <i><a href="/wiki/Gen._Eng._Biotechnol._News" class="mw-redirect" title="Gen. Eng. Biotechnol. News">Gen. Eng. Biotechnol. News</a></i> (paper). <b>34</b> (4). February 15, 2014. p. 41.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gen.+Eng.+Biotechnol.+News&amp;rft.atitle=People&amp;rft.volume=34&amp;rft.issue=4&amp;rft.pages=41&amp;rft.date=2014-02-15&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncyte" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-url_GEN_News_Highlights-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-url_GEN_News_Highlights_13-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/incyte-to-co-develop-hengrui-s-shr-1210-in-up-to-795m-deal/81251695">"Incyte to Co-Develop Hengrui's SHR-1210 in Up-to-$795M+ Deal"</a>. <i>Genetic Engineering &amp; Biotechnology News</i>. 2 September 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=Incyte+to+Co-Develop+Hengrui%27s+SHR-1210+in+Up-to-%24795M%2B+Deal&amp;rft.date=2015-09-02&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fincyte-to-co-develop-hengrui-s-shr-1210-in-up-to-795m-deal%2F81251695&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AIncyte" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
</ol></div></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(3)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><a href="/w/index.php?title=Incyte&amp;action=edit&amp;section=3" title="Edit section: External links" data-section="3" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-3 collapsible-block" id="mf-section-3">
<ul><li>Business data for Incyte: <div class="hlist hlist-separated inline"><ul><li><a rel="nofollow" class="external text" href="https://www.google.com/finance?q=INCY">Google Finance</a></li><li><a rel="nofollow" class="external text" href="https://finance.yahoo.com/q?s=INCY">Yahoo! Finance</a></li><li><a rel="nofollow" class="external text" href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=INCY">SEC filings</a></li></ul></div></li></ul>




</section></div><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1&amp;mobile=1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Incyte&amp;oldid=928014151">https://en.wikipedia.org/w/index.php?title=Incyte&amp;oldid=928014151</a>"</div>
</div>
			<div class="post-content" id="page-secondary-actions">
			
			</div>
		</main>
		<footer class="minerva-footer">
		<div class="last-modified-bar">
	<div class="post-content last-modified-bar__content">
		<span class="last-modified-bar__icon mw-ui-icon mw-ui-icon-mw-ui-icon-small mw-ui-icon-wikimedia-history-base20 "></span>
		<a class="last-modified-bar__text" href="/wiki/Special:History/Incyte"
				data-user-name="Dawnseeker2000"
				data-user-gender="male"
				data-timestamp="1574749555">
				<span>Last edited on 26 November 2019, at 06:25</span>
		</a>
		<span class="mw-ui-icon mw-ui-icon-small mw-ui-icon-mf-expand-gray mf-mw-ui-icon-rotate-anti-clockwise indicator"></span>
	</div>
</div>

		<div class="post-content footer-content">
			<div id='mw-data-after-content'>
	<div class="read-more-container"></div>
</div>

			<h2><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></h2>
			<div class="license">Content is available under <a class="external" rel="nofollow" href="https://creativecommons.org/licenses/by-sa/3.0/">CC BY-SA 3.0</a> unless otherwise noted.</div>
			<ul class="footer-places hlist hlist-separated">
				<li id="footer-places-terms-use"><a href="//m.wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a></li><li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Privacy_policy" class="extiw" title="wmf:Privacy policy">Privacy</a></li><li id="footer-places-desktop-toggle"><a id="mw-mf-display-toggle" href="//en.wikipedia.org/w/index.php?title=Incyte&amp;mobileaction=toggle_view_desktop">Desktop</a></li>
			</ul>
		</div>
		</footer>
	</div>
</div>
<div class="mw-notification-area" data-mw="interface"></div>
<!-- v:8.3.0 -->

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.272","walltime":"0.419","ppvisitednodes":{"value":1449,"limit":1000000},"postexpandincludesize":{"value":47328,"limit":2097152},"templateargumentsize":{"value":2153,"limit":2097152},"expansiondepth":{"value":13,"limit":40},"expensivefunctioncount":{"value":1,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":41858,"limit":5000000},"entityaccesscount":{"value":2,"limit":400},"timingprofile":["100.00%  364.641      1 -total"," 50.60%  184.526      1 Template:Reflist"," 41.83%  152.533      1 Template:Infobox_company"," 37.55%  136.905      1 Template:Infobox"," 32.67%  119.141      6 Template:Cite_web"," 16.31%   59.457      1 Template:Br_separated_entries"," 13.32%   48.583      4 Template:Wikidata","  5.71%   20.806      1 Template:Cite_journal","  4.89%   17.844      4 Template:Cite_news","  3.35%   12.232      1 Template:NASDAQ-100"]},"scribunto":{"limitreport-timeusage":{"value":"0.141","limit":"10.000"},"limitreport-memusage":{"value":5125611,"limit":52428800}},"cachereport":{"origin":"mw1328","timestamp":"20200416075737","ttl":2592000,"transientcontent":false}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Incyte","url":"https:\/\/en.wikipedia.org\/wiki\/Incyte","sameAs":"http:\/\/www.wikidata.org\/entity\/Q6015591","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q6015591","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2012-05-07T03:00:49Z","dateModified":"2019-11-26T06:25:55Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/en\/5\/5a\/Incyte_logo.svg","headline":"American pharmaceutical company"}</script><script>(window.NORLQ=window.NORLQ||[]).push(function(){var ns,i,p,img;ns=document.getElementsByTagName('noscript');for(i=0;i<ns.length;i++){p=ns[i].nextSibling;if(p&&p.className&&p.className.indexOf('lazy-image-placeholder')>-1){img=document.createElement('img');img.setAttribute('src',p.getAttribute('data-src'));img.setAttribute('width',p.getAttribute('data-width'));img.setAttribute('height',p.getAttribute('data-height'));img.setAttribute('alt',p.getAttribute('data-alt'));p.parentNode.replaceChild(img,p);}}});</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":104,"wgHostname":"mw1369"});});</script>		</body>
		</html>
		